AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 293: H3246-H3253, 2007. First published October 12, 2007; doi:10.1152/ajpheart.00957.2007
0363-6135/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/6/H3246    most recent
00957.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, X.
Right arrow Articles by Wilcox, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, X.
Right arrow Articles by Wilcox, C. S.

CALL FOR PAPERS
Cardiovascular-Renal Mechanisms in Health and Disease

Acute antihypertensive action of Tempol in the spontaneously hypertensive rat

Xueguang Chen, Kinjal Patel, Stephanie G. Connors, Margarida Mendonca, William J. Welch, and Christopher S. Wilcox

Division of Nephrology and Hypertension, Clinical Pharmacology, and Angiogenesis Program, Lombardi Cancer Institute and Cardiovascular Kidney Hypertension Institute, Georgetown University, Washington, District of Columbia

Submitted 16 August 2007 ; accepted in final form 9 October 2007

Acute intravenous Tempol reduces mean arterial pressure (MAP) and heart rate (HR) in spontaneously hypertensive rats. We investigated the hypothesis that the antihypertensive action depends on generation of hydrogen peroxide, activation of heme oxygenase, glutathione peroxidase or potassium conductances, nitric oxide synthase, and/or the peripheral or central sympathetic nervous systems (SNSs). Tempol caused dose-dependent reductions in MAP and HR (at 174 µmol/kg; {Delta}MAP, –57± 3 mmHg; and {Delta}HR, –50 ± 4 beats/min). The antihypertensive response was unaffected by the infusion of a pegylated catalase or by the inhibition of catalase with 3-aminotriazole, inhibition of glutathione peroxidase with buthionine sulfoximine, inhibition of heme oxygenase with tin mesoporphyrin, or inhibition of large-conductance Ca2+-activated potassium channels with iberiotoxin. However, the antihypertensive response was significantly (P < 0.01) blunted by 48% by the activation of adenosine 5'-triphosphate-sensitive potassium (KATP) channels with cromakalim during maintenance of blood pressure with norepinephrine and by 31% by the blockade of these channels with glibenclamide, by 40% by the blockade of nitric oxide synthase with N{omega}-nitro-L-arginine methyl ester (L-NAME), and by 40% by the blockade of ganglionic autonomic neurotransmission with hexamethonium. L-NAME and hexamethonium were additive, but glibenclamide and hexamethonium were less than additive. The central administration of Tempol was ineffective. The acute antihypertensive action of Tempol depends on the independent effects of potentiation of nitric oxide and inhibition of the peripheral SNS that involves the activation of KATP channels.

superoxide dismutase; nitric oxide synthase; sympathetic nervous system; catalase; adenosine 5'-triphosphate-activated potassium channels



Address for reprint requests and other correspondence: C. S. Wilcox, Georgetown Univ., Div. of Nephrology and Hypertension, 3800 Reservoir Rd. NW, PHC F6003, Washington, DC 20007 (e-mail: wilcoxch{at}georgetown.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.